Inhibitory action of reveromycin a on TGF-α-dependent growth of ovarian carcinoma bg-1 in vitro and in vivo

Oncology Research

Volumn 9, Issue 1, 1997, Pages 7-11

  Takahashi, Hidetoshi ^a   Yamashita, Yasushi ^a   Takaoka, Hiroaki ^a   Nakamura, Junji ^b   Yoshihama, Makoto ^b   Osada, Hiroyuki ^b  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

17 estradiol; Antitumor; BG 1; Ovarian carcinoma; Reveromycin a; Tgf

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; GROWTH INHIBITOR; PYRAN DERIVATIVE; REVEROMYCIN A; SPIRO COMPOUND; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ARTICLE; CARCINOMA; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FEMALE; HUMAN; MOUSE; OVARY TUMOR;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; CELL DIVISION; FEMALE; GROWTH INHIBITORS; HUMANS; MICE; OVARIAN NEOPLASMS; PYRANS; SPIRO COMPOUNDS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0030628559     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Derynck, R.; Goeddle, D. V.; Ullrich, J.; Gutterman, J. V.; Williams, R. D.; Bringman, T. S.; Berger, W. H. Synthesis of messenger RNAs for transforming growth factors a and and the epidermal growth factor receptor by human tumors. Cancer Res. 47:707-712; 1987.
2. Heldin, C.-H.; Westermark, B. Growth factors: Mechanism of action and relation to oncogenes. Cell 37:9-20; 1984.
3. Umezawa, H.; Imoto, M.; Sawa, T.; Isshiki, K.; Matsuda, M.; Uchida, T.; linuma, H.; Hamada, M.; Takeuchi, T. Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. J. Antibiot. 39:170173; 1986.
4. Toi, M.; Mukaida, H.; Wada, T.; Hirabayashi, N.; Toge, T.; Hori, T.; Umezawa, K. Anti-neoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice. Eur. J. Cancer 26:722-724; 1990.
5. Raymond, M. L.; Sher, Z.; Aviv, G.; Chaim, G.; Alexander, L.; Joseph, S. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J. Biol. Chem. 264:14503-14509; 1989.
6. Osada, H.; Koshino, H.; Isono, K.; Takahashi, H.; Kawanishi, G. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot. 44: 259-261;1991.
7. Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties. J. Antibiot. 45:1409-1413; 1992.
8. Koshino, H.; Takahash, H.; Osada, H.; Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycin A, B, C and D. J. Antibiot. 45:14201427; 1992.
9. Takahashi, H.; Osada, H.; Koshino, H.; Sasaki, H.; Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. J. Antibiot. 45:1414-1419; 1992.
10. Stromberg, K.; Collins, T. J.; Gordon, A. W.; Jackson, C. L.; Johnson, G. R. Transforming growth factor-acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res. 52:341-347; 1992.
11. Zimniski, S. J.; Carola, R. E.; Pendel, K.; Peterson, C. M. Endocrine characterization of a human ovarian carcinoma (BG-1) established in nude mice. Steroids 54:593-606; 1989.
12. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application of proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63; 1983.
13. Geran, R. I.; Greenberg, N. H.; MacDonald, M. M.; Schumacher, A. M.; Abbot, B. J. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. Part 3. 3:1-103; 1972.
14. Kitawaki, J.; Fukuoka, M.; Yamamoto, T.; Honjo, H.; Okada, H. Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 42:267-277; 1992.
15. Umezawa, K.; Hori, T.; Tajima, H.; Imoto, M.; Isshiki, K.; Takeuchi, T. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. FEES Lett. 260: 198-200; 1990.
16. Oyama, S.; Izutsu, T. Cell cycle analysis of endometrial cancer cells in vitro treated with growth factor and steroid hormone. Human Cell 5:363-371; 1992.
17. Morishige, K.; Kurachi, H.; Amemiya, K.; Fujita, Y.; Yamamoto, T.; Miyaké, A.; Tanizawa, O. Evidence for the involvement of transforming growth factor a and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res. 51:5322-5328; 1991.
18. Morishige, K.; Kurachi, H.; Amemiya, K.; Adachi, H.; Inoue, M.; Miyake, A.; Tanizawa, O.; Sakoyama, Y. Involvement of transforming growth factor a/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro. Cancer Res. 51:5951-5955; 1991.
19. Ignar-Trowbridge, D. M.; Nelson, K. G.; Bidwell, M. C.; Curtis, S. W.; Washburn, T. F.; McLachlan, J. A.; Korach, K. S. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sei. USA 89:4658-4662; 1992.
20. Ignar-Trowbridge, D. M.; Teng, C. T.; Ross, K. A.; Parker, M. G.; Korach, K. S.; McLachlan, J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7: 992-998;1993.